Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACARBAZINE vs DACLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACARBAZINE vs DACLIZUMAB: Safety Overview

Metric DACARBAZINE DACLIZUMAB
Total FAERS Reports 5,105 2,801
Deaths Reported 847 193
Death Rate 16.6% 6.9%
Hospitalizations 1,914 835
Average Patient Age 45.5 yrs 45.7 yrs
% Female Patients 47.8% 81.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Fresenius Kabi USA, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription